Sanofi pours $1 billion into China for insulin plant

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Lots on the table today about AI-driven drug discovery, including some startups to watch in this space. Also, we’ve updated our obesity drug tracker and we talk about Gilead’s new cancer deal.

Read the rest…